Managing Burnout in the Pharmacy
Pharmacy Times
SEPTEMBER 25, 2023
Physical symptoms of burnout can include headaches, digestive problems, sleep disturbances, and increased susceptibility to illnesses due to a weakened immune system.
Pharmacy Times
SEPTEMBER 25, 2023
Physical symptoms of burnout can include headaches, digestive problems, sleep disturbances, and increased susceptibility to illnesses due to a weakened immune system.
Drug Topics
SEPTEMBER 26, 2023
Pharmacists at nearly 2 dozen CVS pharmacy locations called out sick Thursday and Friday to protest recent corporate decisions they say put patients at risk of serious harm.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
SEPTEMBER 27, 2023
Working together, pharmacies and labs can answer the call to align and back legislation that supports pharmacists as providers, help patients gain greater access to affordable care, and reap the benefits of improved health outcomes while growing business revenue.
STAT
SEPTEMBER 29, 2023
The World Health Organization has recommended dropping a component of many flu vaccines because the viruses it protects against appear to have been driven into extinction in the Covid-19 pandemic. A family of viruses known as influenza B/Yamagata has not been seen since March 2020, when flu circulation worldwide declined to very low levels in the face of the onslaught of Covid and the protections people took to avoid contracting it.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
SEPTEMBER 27, 2023
Amazon announced this week that it would invest up to $4 billion in artificial intelligence company Anthropic as the AI arms race heats up. | Amazon announced this week that it would invest up to $4 billion in artificial intelligence company Anthropic as the AI arms race heats up. The collaboration introduces more competition and more options for healthcare teams looking to innovate using different approaches or to get more tactical with their AI strategy, one health IT expert said.
Drug Topics
SEPTEMBER 29, 2023
When rural areas lose hospitals and primary care clinics, residents must turn to pharmacies to receive the care they need.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
SEPTEMBER 28, 2023
WASHINGTON — After Pfizer and Moderna hiked the prices of their Covid-19 vaccines this year, the federal government will now pay nearly three times more than it did previously for each dose. And it’s paying more than countries that did far less to support vaccine development. Health and Human Services Secretary Xavier Becerra glossed over the dramatic increase in the amount the government is paying for vaccines in a public appearance last week, when he got vaccinated at a CVS pharm
Fierce Healthcare
SEPTEMBER 25, 2023
Healthcare organizations are continuing to push the Centers for Medicare & Medicaid Services (CMS) to rethink its coverage policy for anti-obesity medications. | Critics say that the view CMS has of certain anti-obesity medications is outdated and could be covered under Medicare Part D.
Drug Topics
SEPTEMBER 29, 2023
After several walkouts protesting poor working conditions, company executives and protest organizers came to an agreement that includes more hours for technicians and vaccinations being reduced to a manageable volume.
Pharmacy Times
SEPTEMBER 25, 2023
For community pharmacists, cooler temperatures, school buses on the roads and Friday night football are not just signs of a changing season – they are indicators that patients will soon be seeking vaccinations for the 2023-2024 respiratory illness season.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
SEPTEMBER 28, 2023
New data released Thursday by the National Science Foundation show the exodus of young life scientists from the Ivory Tower to industry has reached the highest level in nearly three decades, deepening concerns about the future of academic science in the U.S. Among newly minted life science Ph.D.s in 2022 who had firm next steps, roughly 53% planned to pursue postdoctoral research, a temporary period of additional training that is virtually a requirement for those hoping to land a faculty job.
Fierce Healthcare
SEPTEMBER 25, 2023
Costco is joining retail competitors Walgreens, Walmart and CVS Health by expanding its healthcare footprint. | The big-box retailer teamed up with startup Sesame to offer special discount pricing to Costco members on a broad range of outpatient medical care services, including telehealth visits.
Drug Topics
SEPTEMBER 29, 2023
A new poll from the organization surveyed 10000 independent community pharmacy owners on current worries in the industry and how they are being impacted by the ongoing national drug shortage.
Pharmacy Times
SEPTEMBER 29, 2023
Ruben A. Mesa, MD, FACP, discusses the results of the SIMPLIFY-1 and MOMENTUM trials and how the data led to the approval of momelotinib to treat intermediate or high-risk myelofibrosis in adult patients with anemia.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
SEPTEMBER 27, 2023
On a mild May day in 1993, about 60 scientists and doctors gathered on a lawn in Copenhagen to commemorate the first International Symposium on GLP-1, the hormone that decades later would become the basis for highly effective diabetes and obesity drugs like Ozempic and Wegovy. The meeting was a scientific showcase of all the leading experts in the nascent field.
Fierce Pharma
SEPTEMBER 25, 2023
More than five years after an initial FDA approval, Novartis is touting positive trial results for its radiotherapy Lutathera as a first-line therapy against the rare cancer that killed Apple co-fo | More than five years after an initial FDA approval, Novartis is touting positive trial results for its radiotherapy Lutathera as a first-line therapy against the rare cancer that killed Apple co-founder Steve Jobs.
Drug Topics
SEPTEMBER 27, 2023
The class action lawsuit against CVS Health, Caremark, and Aetna was announced earlier today.
Pharmacy Times
SEPTEMBER 28, 2023
Gepirone hydrochloride ER (Exxua; Fabre-Kramer Pharmaceuticals Inc) is in a new class of antidepressants, making it the first and only approved antidepressant that selectively targets serotonin 1A receptors.
STAT
SEPTEMBER 27, 2023
Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation. Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.
Fierce Pharma
SEPTEMBER 28, 2023
Fabre-Kramer Pharmaceuticals' major depressive disorder (MDD) drug gepirone has been rejected by the FDA not once, not twice, but three times since the turn of the millennium. | Fabre-Kramer's Exxua suffered three prior FDA rejections before scoring an FDA approval for major depressive disorder last week. Its label doesn't include sexual dysfunction as an adverse reaction, which is rare among antidepressants.
Drug Topics
SEPTEMBER 28, 2023
A new study from Dartmouth College found that patients maintained healthier blood sugar levels from April to September.
Pharmacy Times
SEPTEMBER 28, 2023
The National Community Pharmacists Association said the action was sent into motion by wrongful penalties for Medicare Part D prescriptions, called pharmacy direct and indirect remuneration fees.
STAT
SEPTEMBER 28, 2023
Vaccination rates against flu and Covid-19 have declined since earlier in the pandemic and a new survey suggests significant portions of the U.S. population intend to forgo these vaccines this fall. The survey, conducted by the National Foundation for Infectious Diseases, suggests only about one in five Americans worry that they or someone in their family will contract influenza, Covid, or RSV — respiratory syncytial virus.
Fierce Healthcare
SEPTEMBER 27, 2023
Despite the challenging funding market, startups focused on women's health and menopause care continue to attract investors who see an untapped market. | The startup, which launched about a year ago, focuses exclusively on women navigating midlife hormonal transition. Midi offers evidence-based interventions ranging from lifestyle coaching and supplements to prescription medications, all covered by major insurance providers.
Fierce Pharma
SEPTEMBER 29, 2023
After a former human resources officer blew the whistle on alleged manufacturing shortfalls at Eli Lilly’s massive Branchburg, New Jersey, production plant, the parties have been engaged in settlem | After a former human resources officer blew the whistle on alleged manufacturing shortfalls at Eli Lilly’s massive Branchburg, New Jersey, production plant, the parties have been engaged in settlement talks.
Pharmacy Times
SEPTEMBER 28, 2023
At a 6-month follow-up, supplemental creatine intervention significantly improved scores for fatigue symptoms and tissue bioenergetics related to COVID-19 infection.
STAT
SEPTEMBER 26, 2023
The latest rollout of Covid-19 vaccines has been messy, with people facing more challenges getting one of the updated shots than they may have experienced since the frantic start of the very first vaccination campaign in late 2020 and the first half of 2021. The issues have come as a surprise to people whose appointments have been canceled for lack of vaccine doses, who couldn’t get an appointment at their nearest pharmacy, or who learned with dismay that the place where they got previous
Fierce Healthcare
SEPTEMBER 27, 2023
As new primary care models, including retail health clinics, continue to scale, the national supply of clinical providers will become even more constrained. | As new primary care models, including retail health clinics, continue to scale, the national supply of clinical providers will become even more constrained. For health systems, hospitals and medical groups, competition for the shrinking pool of nurses and doctors will intensify, according to a new analysis.
Hospital Pharmacy Europe
SEPTEMBER 25, 2023
The benefits of ensitrelvir use in patients with symptoms of long Covid and as a second-line treatment option for those hospitalised with Covid-19, have been presented at the recent European Scientific Working Group on Influenza and other Acute Respiratory Viruses’ (ESWI) Influenza Conference. Ensitrelvir is an oral antiviral drug for Covid-19 manufactured by Shionogi, which is currently approved under the emergency regulatory approval system in Japan.
Pharmacy Times
SEPTEMBER 29, 2023
The most persuasive reason for industry-academia collaboration is the many opportunities it opens for pharmacy students who may not have considered all the ways they can use their PharmD to serve the cause of humankind.
STAT
SEPTEMBER 25, 2023
The pressures of the last three and a half years have affected every corner of the health care landscape, but nowhere is the effect more evident than the country’s physician workforce. Burnout, staffing shortages, financial challenges, administrative burden, and two U.S. Supreme Court decisions that stand to stifle diversity and representation in medicine have hamstrung physicians across specialties and settings — in rural and urban communities, in hospitals, clinics, and independe
Fierce Healthcare
SEPTEMBER 27, 2023
Big players continue to make hefty investments in health tech—look no further than Amazon expanding its virtual clinic to all 50 states and the planned $3 billion merger between digital wellness co | Health tech company Wheel has been building for the next evolution of virtual care with an eye toward working with large enterprises, health plans, pharma and nontraditional players like retailers.
Fierce Pharma
SEPTEMBER 25, 2023
After several diabetic patients received a sham version of Roche's Avastin and lost their sight, the Drug Regulatory Authority of Pakistan (DRAP) is halting the sale or distribution of the drug unt | Authorities in Pakistan are investigating the use of altered versions of Roche's Avastin after several diabetic patients who received a sham version of the drug lost their sight.
Pharmacy Times
SEPTEMBER 28, 2023
In this final episode, we spoke with Claudia Fox, MD, MPH, FAAP, an associate professor of pediatrics at the University of Minnesota Medical School in Minneapolis.
Let's personalize your content